FibroGen (FGEN) Stock Forecast, Price Target & Predictions
FGEN Stock Forecast
FibroGen stock forecast is as follows: an average price target of $28.00 (represents a 5179.03% upside from FGEN’s last price of $0.53) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
FGEN Price Target
FGEN Analyst Ratings
Buy
FibroGen Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 02, 2023 | Annabel Samimy | Stifel Nicolaus | $28.00 | $17.32 | 61.66% | 5179.03% |
FibroGen Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.53 | $0.53 | $0.53 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 31, 2024 | William Blair | Market Perform | Market Perform | Hold |
Jan 30, 2023 | William Blair | Outperform | Upgrade | |
Jan 05, 2023 | Bank of America Securities | Buy | Upgrade |
FibroGen Financial Forecast
FibroGen Revenue Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $27.14M | $40.13M | $44.32M | $36.16M | $34.37M | $15.73M | $29.81M | $60.83M | $16.54M | $155.97M | $24.36M | $38.43M | $65.00M | $44.03M |
Avg Forecast | $61.46M | $55.98M | $50.51M | $45.03M | $39.19M | $37.38M | $37.38M | $37.38M | $37.02M | $41.36M | $37.96M | $37.46M | $20.23M | $34.84M | $34.66M | $36.66M | $38.90M | $36.84M | $34.73M | $31.52M | $23.97M | $31.62M | $36.16M | $28.76M | $47.65M | $129.74M | $69.08M | $41.84M | $100.81M | $61.49M |
High Forecast | $65.34M | $59.52M | $53.70M | $47.88M | $41.67M | $39.74M | $39.74M | $39.74M | $39.36M | $43.98M | $40.36M | $39.83M | $21.50M | $34.88M | $34.66M | $36.66M | $41.36M | $36.84M | $36.92M | $33.52M | $25.49M | $31.62M | $36.16M | $28.76M | $47.65M | $129.74M | $69.08M | $41.84M | $100.81M | $61.49M |
Low Forecast | $57.57M | $52.44M | $47.31M | $42.18M | $36.71M | $35.01M | $35.01M | $35.01M | $34.68M | $38.74M | $35.56M | $35.09M | $18.95M | $34.80M | $34.66M | $36.66M | $36.44M | $36.84M | $32.53M | $29.53M | $22.45M | $31.62M | $36.16M | $28.76M | $47.65M | $129.74M | $69.08M | $41.84M | $100.81M | $61.49M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.70% | 1.09% | 1.28% | 1.15% | 1.43% | 0.50% | 0.82% | 2.12% | 0.35% | 1.20% | 0.35% | 0.92% | 0.64% | 0.72% |
Forecast
FibroGen EBITDA Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-87.48M | $-63.48M | $-85.40M | $-75.06M | $-62.54M | $-91.86M | $-70.37M | $-60.41M | $-131.27M | $53.91M | $-128.98M | $-65.78M | $-52.44M | $39.37M |
Avg Forecast | $-50.83M | $-46.30M | $-41.78M | $-37.25M | $-32.42M | $-30.91M | $-30.91M | $-30.91M | $-30.62M | $-34.21M | $-31.40M | $-30.99M | $-16.73M | $-28.82M | $-28.67M | $-62.02M | $-32.18M | $-30.47M | $-28.72M | $-66.34M | $-77.63M | $-27.12M | $-31.01M | $-70.95M | $-40.86M | $-111.25M | $-59.24M | $-72.59M | $-86.45M | $-52.73M |
High Forecast | $-47.61M | $-43.37M | $-39.13M | $-34.89M | $-30.36M | $-28.96M | $-28.96M | $-28.96M | $-28.68M | $-32.05M | $-29.41M | $-29.03M | $-15.67M | $-28.79M | $-28.67M | $-49.62M | $-30.14M | $-30.47M | $-26.91M | $-53.07M | $-62.10M | $-27.12M | $-31.01M | $-56.76M | $-40.86M | $-111.25M | $-59.24M | $-58.07M | $-86.45M | $-52.73M |
Low Forecast | $-54.05M | $-49.23M | $-44.42M | $-39.61M | $-34.47M | $-32.87M | $-32.87M | $-32.87M | $-32.56M | $-36.38M | $-33.38M | $-32.95M | $-17.79M | $-28.85M | $-28.67M | $-74.43M | $-34.21M | $-30.47M | $-30.54M | $-79.60M | $-93.16M | $-27.12M | $-31.01M | $-85.14M | $-40.86M | $-111.25M | $-59.24M | $-87.10M | $-86.45M | $-52.73M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.72% | 2.08% | 2.97% | 1.13% | 0.81% | 3.39% | 2.27% | 0.85% | 3.21% | -0.48% | 2.18% | 0.91% | 0.61% | -0.75% |
Forecast
FibroGen Net Income Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-55.44M | $-63.62M | $-87.68M | $-77.50M | $-66.45M | $-92.06M | $-73.19M | $-63.52M | $-134.42M | $49.80M | $-133.99M | $-71.75M | $-58.63M | $33.00M |
Avg Forecast | $28.00M | $25.21M | $22.34M | $19.43M | $-3.25M | $-4.62M | $-6.07M | $-6.13M | $-9.05M | $-8.04M | $-11.06M | $-9.05M | $-22.11M | $-30.79M | $-32.16M | $-65.24M | $-42.72M | $-68.46M | $-70.75M | $-69.78M | $-79.29M | $-80.87M | $-92.01M | $-74.63M | $-66.18M | $-698.85K | $-48.12M | $-79.18M | $-23.36M | $-79.87M |
High Forecast | $30.31M | $27.28M | $24.18M | $21.03M | $-2.98M | $-4.24M | $-5.57M | $-5.63M | $-8.30M | $-7.38M | $-10.15M | $-8.30M | $-20.29M | $-28.25M | $-29.52M | $-52.19M | $-39.20M | $-62.83M | $-64.93M | $-55.82M | $-63.43M | $-80.87M | $-92.01M | $-59.70M | $-66.18M | $-698.85K | $-48.12M | $-63.34M | $-23.36M | $-79.87M |
Low Forecast | $25.70M | $23.14M | $20.51M | $17.83M | $-3.51M | $-5.00M | $-6.57M | $-6.64M | $-9.79M | $-8.70M | $-11.97M | $-9.79M | $-23.93M | $-33.32M | $-34.81M | $-78.29M | $-46.23M | $-74.09M | $-76.57M | $-83.73M | $-95.15M | $-80.87M | $-92.01M | $-89.55M | $-66.18M | $-698.85K | $-48.12M | $-95.01M | $-23.36M | $-79.87M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.30% | 0.93% | 1.24% | 1.11% | 0.84% | 1.14% | 0.80% | 0.85% | 2.03% | -71.26% | 2.78% | 0.91% | 2.51% | -0.41% |
Forecast
FibroGen SG&A Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $24.22M | $25.57M | $31.18M | $34.27M | $33.97M | $29.90M | $30.26M | $30.56M | $34.74M | $25.85M | $32.55M | $30.78M | $42.25M | $-48.98M |
Avg Forecast | $40.86M | $37.22M | $33.58M | $29.94M | $26.06M | $24.85M | $24.85M | $24.85M | $24.61M | $27.50M | $25.24M | $24.91M | $13.45M | $23.16M | $23.04M | $31.55M | $25.86M | $24.49M | $23.09M | $20.96M | $20.54M | $21.02M | $24.04M | $19.12M | $31.68M | $86.26M | $45.93M | $33.96M | $67.02M | $40.88M |
High Forecast | $43.44M | $39.57M | $35.70M | $31.83M | $27.70M | $26.42M | $26.42M | $26.42M | $26.17M | $29.24M | $26.83M | $26.48M | $14.30M | $23.19M | $23.04M | $37.86M | $27.50M | $24.49M | $24.55M | $22.28M | $24.65M | $21.02M | $24.04M | $19.12M | $31.68M | $86.26M | $45.93M | $40.76M | $67.02M | $40.88M |
Low Forecast | $38.27M | $34.86M | $31.45M | $28.05M | $24.41M | $23.28M | $23.28M | $23.28M | $23.06M | $25.76M | $23.64M | $23.33M | $12.60M | $23.14M | $23.04M | $25.24M | $24.23M | $24.49M | $21.63M | $19.63M | $16.43M | $21.02M | $24.04M | $19.12M | $31.68M | $86.26M | $45.93M | $27.17M | $67.02M | $40.88M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.04% | 1.35% | 1.64% | 1.65% | 1.42% | 1.26% | 1.60% | 1.10% | 0.30% | 0.71% | 0.91% | 0.63% | -1.20% |
Forecast
FibroGen EPS Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.57 | $-0.65 | $-0.90 | $-0.82 | $-0.71 | $-0.98 | $-0.78 | $-0.68 | $-1.45 | $0.54 | $-1.45 | $-0.78 | $-0.64 | $0.36 |
Avg Forecast | $0.28 | $0.25 | $0.22 | $0.19 | $-0.03 | $-0.05 | $-0.06 | $-0.06 | $-0.09 | $-0.08 | $-0.11 | $-0.09 | $-0.22 | $-0.31 | $-0.32 | $-0.42 | $-0.42 | $-0.68 | $-0.70 | $-0.75 | $-0.94 | $-0.81 | $-0.92 | $-0.83 | $-0.66 | $-0.01 | $-0.48 | $-0.87 | $-0.23 | $-0.80 |
High Forecast | $0.30 | $0.27 | $0.24 | $0.21 | $-0.03 | $-0.04 | $-0.06 | $-0.06 | $-0.08 | $-0.07 | $-0.10 | $-0.08 | $-0.20 | $-0.28 | $-0.29 | $-0.38 | $-0.39 | $-0.63 | $-0.65 | $-0.69 | $-0.86 | $-0.81 | $-0.92 | $-0.83 | $-0.66 | $-0.01 | $-0.48 | $-0.87 | $-0.23 | $-0.80 |
Low Forecast | $0.26 | $0.23 | $0.20 | $0.18 | $-0.03 | $-0.05 | $-0.07 | $-0.07 | $-0.10 | $-0.09 | $-0.12 | $-0.10 | $-0.24 | $-0.33 | $-0.35 | $-0.45 | $-0.46 | $-0.74 | $-0.76 | $-0.82 | $-1.02 | $-0.81 | $-0.92 | $-0.83 | $-0.66 | $-0.01 | $-0.48 | $-0.87 | $-0.23 | $-0.80 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.34% | 0.95% | 1.28% | 1.09% | 0.76% | 1.21% | 0.85% | 0.82% | 2.19% | -77.14% | 3.01% | 0.90% | 2.74% | -0.45% |
Forecast
FibroGen Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
HEPA | Hepion Pharmaceuticals | $0.52 | $70.00 | 13361.54% | Buy |
FGEN | FibroGen | $0.35 | $28.00 | 7900.00% | Buy |
STRO | Sutro Biopharma | $2.09 | $13.00 | 522.01% | Buy |
BMEA | Biomea Fusion | $4.64 | $23.33 | 402.80% | Buy |
GOSS | Gossamer Bio | $0.87 | $3.75 | 331.03% | Buy |
ZURA | Zura Bio | $2.51 | $10.00 | 298.41% | Buy |
LRMR | Larimar Therapeutics | $4.32 | $17.00 | 293.52% | Buy |
CGEM | Cullinan Oncology | $11.49 | $34.00 | 195.91% | Buy |
ARDX | Ardelyx | $4.66 | $11.00 | 136.05% | Buy |
MREO | Mereo BioPharma Group | $3.40 | $8.00 | 135.29% | Buy |
SNDX | Syndax Pharmaceuticals | $13.63 | $31.67 | 132.36% | Buy |
STOK | Stoke Therapeutics | $12.10 | $26.50 | 119.01% | Buy |
DAWN | Day One Biopharmaceuticals | $12.64 | $24.00 | 89.87% | Buy |
MRUS | Merus | $44.90 | $81.25 | 80.96% | Buy |
PCVX | Vaxcyte | $89.86 | $148.80 | 65.59% | Buy |
AKRO | Akero Therapeutics | $30.61 | $50.00 | 63.35% | Buy |
LYEL | Lyell Immunopharma | $0.65 | $1.00 | 53.85% | Hold |
VSTM | Verastem | $4.60 | $7.00 | 52.17% | Buy |
RVMD | Revolution Medicines | $45.16 | $65.67 | 45.42% | Buy |
BMRN | BioMarin Pharmaceutical | $67.19 | $94.43 | 40.54% | Buy |
AGIO | Agios Pharmaceuticals | $41.96 | $53.50 | 27.50% | Buy |
BPMC | Blueprint Medicines | $96.48 | $122.60 | 27.07% | Buy |